Your browser doesn't support javascript.
loading
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic Steatohepatitis.
Tseng, Chih-Ming Leo; Balic, Kemal; Charlton, R Will; Margalit, Maya; Mansbach, Hank; Savic, Rada M.
Affiliation
  • Tseng CL; Clinical Development, 89bio, Inc., San Francisco, California, USA.
  • Balic K; Clinical Development, 89bio, Inc., San Francisco, California, USA.
  • Charlton RW; Clinical Development, 89bio, Inc., San Francisco, California, USA.
  • Margalit M; Clinical Development, 89bio, Inc., Herzliya, Israel.
  • Mansbach H; Clinical Development, 89bio, Inc., San Francisco, California, USA.
  • Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.
Clin Pharmacol Ther ; 114(6): 1323-1331, 2023 12.
Article in En | MEDLINE | ID: mdl-37696614
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States